Diffusion of surgical innovations, patient safety, and minimally invasive radical prostatectomy.

IMPORTANCE Surgical innovations disseminate in the absence of coordinated systems to ensure their safe integration into clinical practice, potentially exposing patients to increased risk for medical error. OBJECTIVE To investigate associations of patient safety with the diffusion of minimally invasive radical prostatectomy (MIRP) resulting from the development of the da Vinci robot. DESIGN, SETTING, AND PARTICIPANTS A cohort study of 401 325 patients in the Nationwide Inpatient Sample who underwent radical prostatectomy during MIRP diffusion between January 1, 2003, and December 31, 2009. MAIN OUTCOMES AND MEASURES We used Agency for Healthcare Research and Quality Patient Safety Indicators (PSIs), which measure processes of care and surgical provider performance. We estimated the prevalence of MIRP among all prostatectomies and compared PSI incidence between MIRP and open radical prostatectomy in each year during the study. We also collected estimates of MIRP incidence attributed to the manufacturer of the da Vinci robot. RESULTS Patients who underwent MIRP were more likely to be white (P = .004), have fewer comorbidities (P = .02), and have undergone surgery in higher-income areas (P = .005). The incidence of MIRP was substantially lower than da Vinci manufacturer estimates. Rapid diffusion onset occurred in 2006, when MIRP accounted for 10.4% (95% CI, 10.2-10.7) of all radical prostatectomies in the United States. In 2005, MIRP was associated with an increased adjusted risk for any PSI (adjusted odds ratio, 2.0; 95% CI, 1.1-3.7; P = .02) vs open radical prostatectomy. Stratification by hospital status demonstrated similar patterns: rapid diffusion onset among teaching hospitals occurred in 2006 (11.7%; 95% CI, 11.3-12.0), with an increased risk for PSI for MIRP in 2005 (adjusted odds ratio, 2.7; 95% CI, 1.4-5.3; P = .004), and onset among nonteaching hospitals occurred in 2008 (27.1%; 95% CI, 26.6-27.7), with an increased but nonsignificant risk for PSI in 2007 (adjusted odds ratio, 2.0; 95% CI, 0.8-5.2; P = .14). CONCLUSIONS AND RELEVANCE During its initial national diffusion, MIRP was associated with diminished perioperative patient safety. To promote safety and protect patients, the processes by which surgical innovations disseminate into clinical practice require refinement.

[1]  S. Lipsitz,et al.  Comparative effectiveness of minimally invasive vs open radical prostatectomy. , 2009, JAMA.

[2]  Philipp Dahm,et al.  Low quality of evidence for robot-assisted laparoscopic prostatectomy: results of a systematic review of the published literature. , 2010, European urology.

[3]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[4]  D. Meadows-Klue The Tipping Point: How Little Things Can Make a Big Difference , 2004 .

[5]  P. Pronovost,et al.  The Occurrence of Potential Patient Safety Events Among Trauma Patients: Are They Random? , 2008, Annals of surgery.

[6]  Marlene R. Miller,et al.  ANational Profile Of Patient Safety In U.S. Hospitals , 2003 .

[7]  P. Dasgupta,et al.  Overcoming the challenges of robot-assisted radical prostatectomy , 2011, Prostate Cancer and Prostatic Diseases.

[8]  J. Skinner,et al.  Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of medicare-age men. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  W. Lowrance,et al.  Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes. , 2010, The Journal of urology.

[10]  J. Cadeddu DO THE OUTCOMES AND COST JUSTIFY THE MARKETING , 2010 .

[11]  L. Feldman,et al.  Evaluation and stages of surgical innovations , 2009, The Lancet.

[12]  L. Kohn,et al.  To Err Is Human : Building a Safer Health System , 2007 .

[13]  S Duke Herrell,et al.  Robotic-assisted laparoscopic prostatectomy: what is the learning curve? , 2005, Urology.

[14]  J. Moul,et al.  The role of early adopter bias for new technologies in robot assisted laparoscopic prostatectomy. , 2007, The Journal of urology.

[15]  M. Menon,et al.  Retropubic, laparoscopic, and robot-assisted radical prostatectomy: a systematic review and cumulative analysis of comparative studies. , 2009, European urology.

[16]  S. Walsh,et al.  Bile duct injuries, 1989-1993. A statewide experience. Connecticut Laparoscopic Cholecystectomy Registry. , 1996, Archives of surgery.

[17]  David I. Lee,et al.  Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons. , 2009, The Journal of urology.

[18]  Charles B. Wilson Adoption of new surgical technology , 2006, BMJ : British Medical Journal.

[19]  Marlene R. Miller,et al.  Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. , 2003, JAMA.

[20]  M. Cohen,et al.  Has laparoscopic cholecystectomy changed patterns of practice and patient outcome in Ontario? , 1996, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[21]  E. Rogers,et al.  Diffusion of innovations , 1964, Encyclopedia of Sport Management.

[22]  W. Lowrance,et al.  Contemporary open and robotic radical prostatectomy practice patterns among urologists in the United States. , 2012, The Journal of urology.

[23]  Stuart R. Lipsitz,et al.  Utilization and outcomes of minimally invasive radical prostatectomy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Makary,et al.  Underreporting of Robotic Surgery Complications , 2015, Journal for healthcare quality : official publication of the National Association for Healthcare Quality.

[25]  J. Cadeddu,et al.  Robotic prostatectomy. , 2010, The Journal of urology.

[26]  J. Parsons,et al.  Outcomes of retropubic, laparoscopic, and robotic-assisted prostatectomy. , 2008, Urology.

[27]  Greg Scandlen Commentary--How consumer-driven health care evolves in a dynamic market. , 2004, Health services research.

[28]  K A Arndt,et al.  Cutting edge , 2012, Archives of dermatology.